Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

09 Aug, 2023

Authors: Turkova A, White E, Kekitiinwa RA, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe MG, Moloantoa T, Srirompotong U, Mosia RN, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi FM, Klein N, Mujuru AH, Kityo C, Cotton FM, Ferrand AR, Giaquinto C, Rojo P,  Violari A, Gibb MD, Ford D, on behalf of the ODYSSEY trial team

Published in: The Lancet: Child and Adolescent Heath